Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

(2011) W Chua et al.   BRITISH JOURNAL OF CANCER

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study

(2011) Harry J.M. Groen et al.   JOURNAL OF CLINICAL ONCOLOGY

C-Reactive Protein and Risk of Lung Cancer

(2010) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer

(2008) Khaled M. Sarraf et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Lung Cancer

(2008) Roy S. Herbst et al.   NEW ENGLAND JOURNAL OF MEDICINE